About Quantum Pharma PLC (LON:QP)
Quantum Pharma Plc is a pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesaler, hospital and homecare markets. The Company's core business is the manufacture, procurement and supply of unlicensed medicines (specials) and special obtains to the United Kingdom pharmacy chains. It operates through three segments: Specials; Niche Pharmaceuticals (Niche), and Medication Adherence (MA). The Specials segment engages in the manufacture, source and supply specials to pharmacies, pharmaceutical wholesalers, hospitals, and other specials suppliers throughout the United Kingdom and overseas. The Niche Pharmaceuticals segment develops and supplies nice pharmaceuticals, provides development and regulatory services, and out-licenses products and dossiers to third parties across Europe. The Medication Adherence segment provides products and services designed to provide adherence to medication regimes.
Industry, Sector and Symbol:
- Market Cap: £139.1 million
- Outstanding Shares: 169,117,000
- 50 Day Moving Avg: GBX 77.22
- 200 Day Moving Avg: GBX 60.03
- 52 Week Range: GBX 32.75 - GBX 87.50
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: £92.9 million
- Price / Sales: 1.50
- Book Value: GBX 0.30 per share
- Price / Book: 2.74
- EBITDA: £6.23 million
- Net Margins: 8.19%
- Return on Equity: 12.20%
- Return on Assets: 6.70%
- Average Volume: 1.75 million shs.
Frequently Asked Questions for Quantum Pharma PLC (LON:QP)
What is Quantum Pharma PLC's stock symbol?
Quantum Pharma PLC trades on the London Stock Exchange (LON) under the ticker symbol "QP."
Who are some of Quantum Pharma PLC's key competitors?
Some companies that are related to Quantum Pharma PLC include Allergy Therapeutics plc (AGY), Neos Therapeutics (NEOS), Marinus Pharmaceuticals (MRNS), BioDelivery Sciences International (BDSI), Adamis Pharmaceuticals Corporation (ADMP), Aralez Pharmaceuticals (ARLZ), Female Health Company (The) (VERU), BioLife Solutions (BLFS), Diurnal Group PLC (DNL), Evoke Pharma (EVOK), SCYNEXIS (SCYX), Juniper Pharmaceuticals (JNP), Concordia International Corp. (CXRX), Histogenics Corporation (HSGX), Amryt Pharma PLC (AMYT), Intellipharmaceutics International (IPCI), Pernix Therapeutics Holdings (PTX) and Cellectar Biosciences (CLRB).
Who are Quantum Pharma PLC's key executives?
Quantum Pharma PLC's management team includes the folowing people:
- Chris Rigg, Chief Executive Officer, Director
- Gerard Thomas Murray, Chief Financial Officer, Director
- George Liolios, Managing Director at Lamda
- Brian Fisher, Joint Managing Director - Special Division
- Nicola Massey, Managing Director - Niche Pharmaceuticals Division
- Andrew Matthews, Joint Managing Director - Special Division
- Ian Pearce, Managing Director - Medication Adherence Division
- Craig Swinhoe, Group Legal and Projects Director and Company Secretary
- Ian Roy Johnson, Non-Executive Chairman of the Board
- Christopher Harwood Bernard Mills, Non-Executive Director
How do I buy Quantum Pharma PLC stock?
Shares of Quantum Pharma PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Quantum Pharma PLC's stock price today?
MarketBeat Community Rating for Quantum Pharma PLC (LON QP)MarketBeat's community ratings are surveys of what our community members think about Quantum Pharma PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Quantum Pharma PLC stock can currently be purchased for approximately GBX 82.25.
Consensus Ratings for Quantum Pharma PLC (LON:QP) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|Consensus Price Target History for Quantum Pharma PLC (LON:QP)
Analysts' Ratings History for Quantum Pharma PLC (LON:QP)
(Data available from 10/19/2015 forward)
|5/3/2017||N+1 Singer||Reiterated Rating||corporate|
Earnings History for Quantum Pharma PLC (LON:QP)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Quantum Pharma PLC (LON:QP)
Current Year EPS Consensus Estimate: $6.85 EPS
Dividend History for Quantum Pharma PLC (LON:QP)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Quantum Pharma PLC (LON:QP)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Quantum Pharma PLC (LON:QP)
Latest Headlines for Quantum Pharma PLC (LON:QP)
Quantum Pharma PLC (QP) Chart for Thursday, October, 19, 2017